Sanara MedTech

Historical price data

Sanara MedTech is a Texas-based medical technology company with a mission to improve clinical outcomes and reduce healthcare expenditures through transformative surgical and wound care products. The company has successfully commercialized a portfolio of regenerative medicine products for soft tissue repair and surgical site management, establishing a revenue-generating foundation. Its strategic focus is now on advancing its flagship OsStic™ bone bioadhesive technology, a high-potential platform with FDA Breakthrough Device Designation, while leveraging its commercial infrastructure for growth.

Expertise in advanced biomaterials and extracellular matrices for tissue repair, centered on a breakthrough phosphoserine-based bone bioadhesive (OsStic™) that bonds to wet bone and remodels.

In commercial wound/surgical care, Sanara competes with large medtech firms and specialized biologics companies. For OsStic™, primary competition comes from traditional bone cements (PMMA) and calcium phosphate cements, though its proposed adhesive and remodeling properties aim to create a new, superior category for specific fracture indications.